An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013

Detalles Bibliográficos
Autores principales: Ribrag, Vincent, Armand, Phillippe, Kuruvilla, John, Michot, Jean-Marie, Moskowitz, Craig H, Marinello, Patricia, Snyder, Ellen, Balakumaran, Arun, Shipp, Margaret A, Zinzani, Pier Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645265/
http://dx.doi.org/10.1186/2051-1426-3-S2-P169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645265/
http://dx.doi.org/10.1186/2051-1426-3-S2-P169

Ejemplares similares